A Phase 1 Study of MEDI7734 in Type I Interferon-Mediated Autoimmune Diseases

Trial Identifier: D6080C00001
Sponsor: MedImmune, LLC
NCTID:: NCT02780674
Start Date: August 2016
Primary Completion Date: October 2017
Condition: Skin, Hair & Nails - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Translation

Trial Locations

Country Location
United States of America, AL Anniston, AL, United States of America, 36207
United States of America, AL Birmingham, AL, United States of America, 35294
United States of America, CT Danbury, CT, United States of America, 06810
United States of America, FL Debary, FL, United States of America, 32713
United States of America, FL Jacksonville, FL, United States of America, 32216
United States of America, FL Miami Springs, FL, United States of America, 33166
United States of America, PA Duncansville, PA, United States of America, 16635